Total Payments
$1,732
2024 Payments
$187.59
Companies
28
Transactions
124
Medicare Patients
3,525
Medicare Billing
$775,556
Payment Breakdown by Category
Food & Beverage$1,732 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,732 | 124 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $371.46 | 28 | $0 (2019) |
| PFIZER INC. | $274.16 | 23 | $0 (2023) |
| Purdue Pharma L.P. | $171.30 | 13 | $0 (2017) |
| Depomed, Inc. | $127.08 | 10 | $0 (2017) |
| Bioventus LLC | $108.30 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $103.06 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $58.30 | 4 | $0 (2024) |
| Mylan Specialty L.P. | $47.02 | 2 | $0 (2023) |
| Lilly USA, LLC | $44.08 | 3 | $0 (2024) |
| Novo Nordisk Inc | $40.05 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187.59 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($89.66) |
| 2023 | $107.50 | 6 | Mylan Specialty L.P. ($24.95) |
| 2020 | $57.85 | 4 | Bioventus LLC ($16.84) |
| 2019 | $409.08 | 27 | Daiichi Sankyo Inc. ($125.55) |
| 2018 | $410.95 | 32 | Daiichi Sankyo Inc. ($220.81) |
| 2017 | $559.18 | 44 | Purdue Pharma L.P. ($171.30) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: DEVICES | ||||||
| 08/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Respiratory | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Gastroenterology | ||||||
| 03/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 03/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Gastroenterology | ||||||
| 10/16/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PAIN | ||||||
| 08/28/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/23/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Endocrinology | ||||||
| 04/11/2023 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 03/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: ANTIBIOTIC | ||||||
| 03/13/2020 | FIDIA PHARMA USA INC. | Hymovis (Device) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Osteoarthritis | ||||||
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/04/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/15/2020 | Bioventus LLC | GELSYN 3 (Device) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Not Applicable | ||||||
| 12/21/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/18/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA, COLOGUARD | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/22/2019 | PFIZER INC. | EMBEDA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/05/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $16.76 | General |
| Category: Musculoskeletal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 577 | 31,049 | $763,073 | $116,311 |
| 2022 | 14 | 784 | 34,867 | $1.0M | $180,807 |
| 2021 | 15 | 1,024 | 42,021 | $1.1M | $245,029 |
| 2020 | 19 | 1,140 | 38,370 | $1.1M | $233,410 |
Total Patients
3,525
Total Services
146,307
Medicare Billing
$775,556
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 557 | $143,149 | $47,125 | 32.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 93 | 375 | $191,874 | $21,404 | 11.2% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 24 | 158 | $149,835 | $15,418 | 10.3% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2023 | 29 | 28,886 | $165,517 | $14,839 | 9.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 84 | $17,808 | $5,388 | 30.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 34 | 50 | $20,176 | $2,822 | 14.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 41 | 89 | $25,276 | $2,048 | 8.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 20 | 51 | $14,484 | $1,960 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,420 | $1,889 | 29.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 14 | 14 | $10,808 | $1,746 | 16.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 12 | 18 | $3,438 | $598.36 | 17.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 78 | 736 | $9,745 | $553.90 | 5.7% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 13 | 16 | $4,544 | $518.72 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 716 | $175,420 | $60,997 | 34.8% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2022 | 35 | 31,910 | $183,328 | $40,011 | 21.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 124 | 558 | $239,343 | $28,627 | 12.0% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2022 | 40 | 209 | $193,246 | $21,736 | 11.2% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2022 | 12 | 103 | $63,795 | $6,027 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 70 | $13,872 | $4,891 | 35.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 74 | 175 | $47,425 | $4,581 | 9.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,792 | $2,903 | 29.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 38 | 61 | $22,570 | $2,809 | 12.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 20 | 20 | $14,120 | $2,252 | 15.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 24 | 40 | $7,280 | $1,440 | 19.8% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 12 | 12 | $4,938 | $1,252 | 25.4% |
About Dr. Glen Imlay, M.D
Dr. Glen Imlay, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Proctorville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053364828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glen Imlay, M.D has received a total of $1,732 in payments from pharmaceutical and medical device companies, with $187.59 received in 2024. These payments were reported across 124 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,732).
As a Medicare-enrolled provider, Imlay has provided services to 3,525 Medicare beneficiaries, totaling 146,307 services with total Medicare billing of $775,556. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation
- Location Proctorville, OH
- Active Since 05/19/2006
- Last Updated 01/21/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1053364828
Products in Payments
- Morphabond ER (Drug) $353.00
- LYRICA (Drug) $235.91
- Nucynta (Drug) $127.08
- XIFAXAN (Drug) $94.95
- HYSINGLA ER (Drug) $65.15
- GELSYN 3 (Device) $50.60
- JARDIANCE (Drug) $44.08
- Durolane (Device) $34.24
- BREZTRI (Drug) $30.39
- ACTHAR (Biological) $29.95
- FARXIGA (Drug) $27.91
- Tresiba (Drug) $27.08
- Vascepa (Drug) $26.24
- BUTRANS (Drug) $25.96
- BUNAVAIL 2.1 mg 30-count box (Drug) $25.08
- YUPELRI (Drug) $24.95
- EMBEDA (Drug) $23.68
- NUZYRA (Drug) $23.57
- GELSYN-3 (Device) $23.46
- EUFLEXXA (Device) $22.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.